Stopped: Due to the termination of the collaboration of ApiFix ltd. and the UMC Utrecht
The primary aim of this study is to investigate the limited efficacy of these innovative surgical solutions in treatment of Early Onset Scoliosis (EOS) in terms of maintaining reduction while maintaining spinal growth. The secondary aim is to compare both devices for these and other parameters as well as safety.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Limited-efficacy of SDS and MID-C in terms of curve correction maintenance: changes in cobb angle
Timeframe: Until 1 year post-operative FU
Incidence of Treatment-Emergent Serious Adverse Events of SDS and MID-C
Timeframe: Until 1 year post-operative FU